We are live on ! Find out more
KALA icon

KALA BIO
KALA

24 hedge funds and large institutions have $5.56M invested in KALA BIO in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

195% more capital inflows, than outflows

Capital inflows: $1.45M | Capital outflows: $493K

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

14% more funds holding

Funds holding: 21 → 24 (+3)

0.48% more ownership

Funds ownership: 15.74% → 16.22% (+0.48%)

Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$612K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$276K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$255K
4
Board of Trustees of The Leland Stanford Junior University
Board of Trustees of The Leland Stanford Junior University
California
+$151K
5
BlackRock
BlackRock
New York
+$76.1K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$227K
2
Samsara BioCapital
Samsara BioCapital
California
-$181K
3
Jane Street
Jane Street
New York
-$35.7K
4
UBS Group
UBS Group
Switzerland
-$29.5K
5
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$13.2K

KALA Hedge Fund Activity: Q2 2023 in Review

24 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q2 2023, worth a combined $5.56M — up 16% from $4.81M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new KALA positions and 3 closed out — a net gain of 3 holders — while 7 added to existing stakes and 4 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $612K. The largest seller was Millennium Management, cutting an estimated $227K.

  • 24 institutional investors held KALA BIO (KALA) as of Q2 2023, up from 21 in Q1 2023.
  • Funds reported $5.56M of KALA BIO stock for Q2 2023, up 16% quarter-over-quarter.
  • 6 funds opened new KALA BIO positions in Q2 2023 and 3 closed out, a net change of +3 holders.
  • The largest KALA BIO buyer in Q2 2023 was Baker Bros. Advisors, an estimated $612K added.
  • The largest KALA BIO seller in Q2 2023 was Millennium Management, an estimated $227K sold.

Based on aggregated 13F filings for Q2 2023.